Menu
Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.
1213 Innsbruck Dr
Sunnyvale, California 94089-1317
Phone: 16505669060
silkroadmed.com
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund (Institutional Shares) declined 7.78% underperforming the 2.92% return for the Russell 2000 Growth Index. The lion’s share of negative attribution and 6.52% of negative performance […]
Silk Road Medical (NASDAQ: SILK ) just reported results for the second quarter of 2024. Silk Road Medical reported earnings per share of -42 cents. This was below the analyst estimate for EPS of -38 cents. The company reported revenue of $51.24 million. This was 3.31% better than the analyst estimate for revenue of $49.60 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post SILK Stock Earnings: Silk Road Medical Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .
No summary available.
SUNNYVALE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2024.
